Here are some of the most notable trials and experiments outlining the peptides potential: According to Kastsiuchenka et al
The best human sleep studies on DSIP date from the 1980s and 1990s, with sample sizes typically under 20 subjects and no modern RCT replication, placing overall evidence confidence at Low to Very Low
In addition, combining treatments may provide a better safety profile given that lower doses of each drug when used together may achieve better weight loss than higher doses of a single agent (see Figure 1 below)
The first two months represented the rising portion of that curve, not the peak
Key areas include: Aging research: Slows functional decline and modulates lifespan-related biomarkers
choline, Inositol, B12, Methionine, B3, B6, B2, B1, Lidocaine HCL Monohydrate, LevoCarnitine